230 related articles for article (PubMed ID: 37554340)
1. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence.
Vacante M; Ciuni R; Basile F; Biondi A
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33182693
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.
Ahmad A; Mahmood N; Raza MA; Mushtaq Z; Saeed F; Afzaal M; Hussain M; Amjad HW; Al-Awadi HM
Heliyon; 2024 Apr; 10(8):e29495. PubMed ID: 38655310
[TBL] [Abstract][Full Text] [Related]
3. Intestinal bacteria and colorectal cancer: etiology and treatment.
Dougherty MW; Jobin C
Gut Microbes; 2023; 15(1):2185028. PubMed ID: 36927206
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
Wang WY; Zhou H; Wang Z; Zhang YH
Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
[TBL] [Abstract][Full Text] [Related]
5. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort.
Butt J; Jenab M; Werner J; Fedirko V; Weiderpass E; Dahm CC; Tjønneland A; Olsen A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Turzanski-Fortner R; Aleksandrova K; Schulze M; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Van Gils CH; Gram IT; Lukic M; Sala N; Sánchez Pérez MJ; Ardanaz E; Chirlaque MD; Palmquist R; Löwenmark T; Travis RC; Heath A; Cross AJ; Freisling H; Zouiouich S; Aglago E; Waterboer T; Hughes DJ
Gut Microbes; 2021; 13(1):1-14. PubMed ID: 33874856
[TBL] [Abstract][Full Text] [Related]
6. Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study.
Abo-Hammam RH; Salah M; Shabayek S; Hanora A; Zakeer S; Khattab RH
AIMS Microbiol; 2024; 10(1):148-160. PubMed ID: 38525041
[TBL] [Abstract][Full Text] [Related]
7. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation.
Garvey M
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672096
[TBL] [Abstract][Full Text] [Related]
9. Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells.
Miyakawa Y; Otsuka M; Shibata C; Seimiya T; Yamamoto K; Ishibashi R; Kishikawa T; Tanaka E; Isagawa T; Takeda N; Kamio N; Imai K; Fujishiro M
Cell Mol Gastroenterol Hepatol; 2024; 17(5):745-767. PubMed ID: 38309455
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Colorectal Cancer: An Umbrella Review of Methodological Trends and Clinical Correlations.
Kasagga A; Hawrami C; Ricci E; Hailu KT; Salib K; Savithri Nandeesha S; Hamid P
Cureus; 2024 Feb; 16(2):e54210. PubMed ID: 38496101
[TBL] [Abstract][Full Text] [Related]
11. An independent evaluation in a CRC patient cohort of microbiome 16S rRNA sequence analysis methods: OTU clustering, DADA2, and Deblur.
Liu G; Li T; Zhu X; Zhang X; Wang J
Front Microbiol; 2023; 14():1178744. PubMed ID: 37560524
[TBL] [Abstract][Full Text] [Related]
12. Incidence, characteristics and risk factors for alveolar recruitment maneuver-related hypotension in patients undergoing laparoscopic colorectal cancer resection.
Zhang NR; Zheng ZN; Wang K; Li H
World J Gastrointest Surg; 2023 Jul; 15(7):1454-1464. PubMed ID: 37555120
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab side effects and adverse clinical complications in colorectal cancer patients: review article.
Minhajat R; Harjianti T; Islam IC; Winarta S; Liyadi YN; Bamatraf NP; Amanuddin R
Ann Med Surg (Lond); 2023 Aug; 85(8):3931-3937. PubMed ID: 37554884
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of Postoperative Adjuvant Chemotherapy in the Population Aged 75 Years and Older with Stage II-III Colorectal Cancer: A Retrospective Multi-Center Cohort Study.
Liu L; Pang X; Zhao K; Chen Y; Li Y; You R; Xu T; Liu M; Wu L; Li Z; Pu H
Int J Gen Med; 2023; 16():3311-3322. PubMed ID: 37554705
[TBL] [Abstract][Full Text] [Related]
15. The histologic features, molecular features, detection and management of serrated polyps: a review.
Wang JD; Xu GS; Hu XL; Li WQ; Yao N; Han FZ; Zhang Y; Qu J
Front Oncol; 2024; 14():1356250. PubMed ID: 38515581
[TBL] [Abstract][Full Text] [Related]
16. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
Gong D; Adomako-Bonsu AG; Wang M; Li J
PeerJ; 2023; 11():e15777. PubMed ID: 37554340
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral presence of the genotoxic gut bacteria pks
Joo JE; Chu YL; Georgeson P; Walker R; Mahmood K; Clendenning M; Meyers AL; Como J; Joseland S; Preston SG; Diepenhorst N; Toner J; Ingle DJ; Sherry NL; Metz A; Lynch BM; Milne RL; Southey MC; Hopper JL; Win AK; Macrae FA; Winship IM; Rosty C; Jenkins MA; Buchanan DD
Br J Cancer; 2024 Mar; 130(5):728-740. PubMed ID: 38200234
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
